- First drug targeting precise genetic mutations in prostate cancer has shown to be effective in trial on 49 patients http://www.nejm.org/doi/full/10.1056/nejmoa1506859 40 comments science
Linked pages
Related searches:
Search whole site: site:www.nejm.org
Search title: DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer | NEJM
See how to search.